Skip to main content

Citadel Advisors LLC

SEC CIK
0001423053
Latest filing
Sep 1, 2026

VIR holding history

Vir Biotechnology, Inc. in every 13F filed by Citadel Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VIR overviewAll 13F holders of VIRFull Q2 2026 holdings

Shares (Q2 2026)
991,337
Value
$10.1M
% of portfolio
<0.1%
Quarters held
20
Since Q1 2021
Holdings of VIR by Citadel Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026991,337$10.1M<0.1%−1,107,139−52.8%ReducedHolders
Q1 20262,098,476$18.8M<0.1%+1,609,250+328.9%AddedHolders
Q4 2025489,226$2.95M<0.1%−309,808−38.8%ReducedHolders
Q3 2025799,034$4.56M<0.1%−2,665,883−76.9%ReducedHolders
Q2 20253,464,917$17.5M<0.1%+1,847,689+114.3%AddedHolders
Q1 20251,617,228$10.5M<0.1%+1,345,964+496.2%AddedHolders
Q4 2024271,264$1.99M<0.1%+2,292+0.9%AddedHolders
Q3 2024268,972$2.01M<0.1%−481,015−64.1%ReducedHolders
Q2 2024749,987$6.67M<0.1%−2,657,845−78.0%ReducedHolders
Q1 20243,407,832$34.5M<0.1%+369,884+12.2%AddedHolders
Q4 20233,037,948$30.6M<0.1%+2,954,409+3,536.6%AddedHolders
Q3 202383,539$782.8K<0.1%+19,568+30.6%AddedHolders
Q2 202363,971$1.57M<0.1%−267,822−80.7%ReducedHolders
Q1 2023331,793$7.72M<0.1%+303,587+1,076.3%AddedHolders
Q4 202228,206$713.9K<0.1%−93,754−76.9%ReducedHolders
Q3 2022121,960$2.35M<0.1%+121,960NewHolders
Q1 20220$00.0%−590,876−100.0%Sold outHolders
Q4 2021590,876$24.7M<0.1%+451,777+324.8%AddedHolders
Q3 2021139,099$6.05M<0.1%+108,342+352.3%AddedHolders
Q2 202130,757$1.45M<0.1%+17,612+134.0%AddedHolders
Q1 202113,145$674.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.